Correction to: Do Limitations in the Design of PARADIGM-HF Justify the Slow Real World Uptake of Sacubitril/Valsartan (Entresto)?
Crossref DOI link: https://doi.org/10.1007/s10557-018-6834-6
Published Online: 2018-10-01
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ahn, Rosa
Prasad, Vinay
Text and Data Mining valid from 2018-10-01
Article History
First Online: 1 October 2018